Worry lines might become deeper
22/11/22 -"FMC’s troubled US business is facing increasing difficulties which will make finding a solution more expensive. In general, the struggle to recruit nurses, i.e. medical staff, will intensify in the ..."
Pages
60
Language
English
Published on
22/11/22
You may also be interested by these reports :
13/10/26
Demant reported robust preliminary Q3 sales figures, driven by strong demand for its newly launched hearing aids. The 2026 guidance has been revised ...
09/10/26
Our target price has been revised downwards due to updated estimates following management’s decision to lower the upper end of its topline guidance ...
08/10/26
Our target price has increased due to a higher NAV and DCF, along with a 20% premium applied to our peer-based valuation metrics, excluding dividend ...
08/10/26
The TP increase reflects upgrades to our DCF and NAV (discussed above). The investment case remains compelling: consumables-led growth, the ...